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Studying the role of essential proteins is dependent
upon a method for rapid inactivation, in order to
study the immediate phenotypic consequences.
Auxin-inducible degron (AID) technology allows
rapid depletion of proteins in animal cells and fungi,
but its application to human cells has been limited
by the difficulties of tagging endogenous proteins.
We have developed a simple and scalable CRISPR/
Cas-based method to tag endogenous proteins in
human HCT116 and mouse embryonic stem (ES)
cells by using donor constructs that harbor synthetic
short homology arms. Using a combination of AID
tagging with CRISPR/Cas, we have generated condi-
tional alleles of essential nuclear and cytoplasmic
proteins in HCT116 cells, which can then be depleted
very rapidly after the addition of auxin to the culture
medium. This approach should greatly facilitate the
functional analysis of essential proteins, particularly
those of previously unknown function.INTRODUCTION
Genetic perturbation is a powerful approach to the analysis of
protein function in vivo. The clustered regularly interspaced
short-palindromic repeats (CRISPR)/CRISPR-associated (Cas)
system-based gene-editing technology has revolutionized the
generation of gene knockouts in human cells (Cong et al.,
2013; Mali et al., 2013). However, some genes are essential
for cellular viability, most of which are involved in processes
that are important for proliferation and the number of which is
estimated to be 2,000 in human cell lines (Blomen et al.,
2015; Hart et al., 2015; Wang et al., 2015). Because these
genes cannot be perturbed constitutively, conditional inactiva-210 Cell Reports 15, 210–218, April 5, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://tion or depletion of encoding proteins is useful for the functional
analysis.
Conditional depletion can be achieved by fusing a destabiliz-
ing domain (so-called degron) that can be conditionally
controlled. We previously used heat-inducible degron technol-
ogy (Dohmen et al., 1994) to study essential budding yeast pro-
teins involved in DNA replication, and we demonstrated that
rapid depletion was important to detect the direct conse-
quences of protein inactivation, before the phenotype became
obscured by secondary effects (Kanemaki et al., 2003). Several
conditional degron technologies, which allow for controlling
the stability of degron-fused proteins by use of a small
molecule, have been established (Banaszynski et al., 2006;
Bonger et al., 2011; Chung et al., 2015; Iwamoto et al., 2010;
Neklesa et al., 2011). We developed an auxin-inducible degron
(AID) technology by transplanting a plant-specific degradation
pathway controlled by a phytohormone, auxin, into non-plant
cells (Nishimura et al., 2009). In cells expressing the auxin
perceptive F-box protein TIR1, which forms a functional SCF
(Skp1–Cullin–F-box) ubiquitin ligase, proteins fused with an
AID tag derived from the IAA17 protein of Arabidopsis thaliana
can be induced for rapid degradation by the addition of auxin
to the culture medium. Crucially, AID technology allows for
conditional depletion that is very rapid, typically with a half-
life of 10–20 min (Holland et al., 2012; Lambrus et al., 2015).
This is much quicker than any of the other degron-based tech-
nologies that utilize a small molecule, which typically yield half-
lives of several hours (reviewed and discussed in Kanemaki,
2013). Furthermore, AID also works in a reversible fashion
and has successfully been used for analysis of essential genes
in fungi, nematodes, and metazoan cells (Holland et al., 2012;
Kanke et al., 2011; Lambrus et al., 2015; Nishimura et al.,
2009; Zhang et al., 2015). However, even though the AID sys-
tem represents a very promising technology for the analysis
of essential genes in human cells, its use has been severely
limited until now, because it is difficult to fuse endogenous pro-
teins with the AID tag.creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. GFP Tagging of the MCM8 Protein Using a Donor Plasmid Harboring Short Homology Arms
(A) Experimental scheme used to tag MCM8 with GFP. A PCR-amplified donor DNA harboring 175-bp homology arms was cloned into pBluescript before
transfection with a CRISPR/Cas plasmid to target the MCM8 locus.
(B) Genomic PCR to test the genotype of clones after selection. Primer sets and expected PCR products are shown in the illustration shown above.
(C) The MCM8–GFP protein was detected using anti-MCM8 and anti-GFP antibodies.
(D) Homozygous MCM8–GFP cells were treated with 1 mg/mL of mitomycin C and 10 mM olaparib to induce DNA damage for 24 hr before microscopic
observation. MCM8–GFP (green) and Hoechst (blue) staining are shown. The scale bar corresponds to 10 mm.To overcome this problem, we established a CRISPR/Cas-
basedmethod for tagging endogenous geneswith donor vectors
carrying synthetic short homology arms in human colorectal can-
cer HCT116 cells, which have a stable diploid karyotype and
have been used for conventional gene targeting (Waldman
et al., 1995). Here, we describe a simple and scalable method
for the generation of conditional human AID mutants of essential
genes using donors carrying synthetic short homology arms, by
means of a single transfection and subsequent cell cloning. To
illustrate the usefulness of this approach, we constructed condi-
tional alleles of the nuclear cohesin and the cytoplasmic dynein
complexes, and we demonstrated that AID-tagged RAD21 co-
hesin subunit was depleted with a half-life of 17 min after the
addition of auxin. Finally, we show that tagging with short-ho-
mology donors also works in mouse embryonic stem (ES) cells,
suggesting that the same strategy can be applied for construc-
tion of conditional AID mutants of mouse ES cells.
RESULTS
Gene Tagging with Donors Harboring Synthetic Short
Homology Arms
We initially wished to establish a simple CRISPR/Cas-based
tagging method to tag endogenous genes of interest before
construction of conditional AID mutants. Using CRISPR/Cas,PCR-amplified linear donors harboring short homology arms
have been used successfully for tagging endogenous genes in
Drosophila S2 cells and in nematodes (Bo¨ttcher et al., 2014;
Paix et al., 2014). We tested this strategy by fusing GFP at the
C terminus of the MCM8 protein using a PCR-amplified linear
DNA carrying 175-bp homology arms as a donor for homol-
ogy-directed repair (HDR) (Figure S1A). We found that insertion
of the GFP cassette was rarely observed (Figure S1B) and
that the MCM8-GFP protein was not expressed in any of the
clones obtained (data not shown). We suspected that the linear
donor DNA might be unstable in cells because of degradation
by exonucleases. Therefore, we cloned the PCR product into a
plasmid and used it as a donor for HDR (Figure 1A). After selec-
tion with G418, we isolated clones and checked the insertion of
the GFP cassette by genomic PCR (Figures 1B and S2). We
found heterozygous or homozygous insertion in up to 24% of
G418-resistant clones (n = 28 and 33). The expression of the
MCM8-GFP fusion protein was confirmed further by immuno-
blotting (Figure 1C). The MCM8-GFP protein formed nuclear
foci upon DNA damage, as shown previously in chicken DT40
cells (Figure 1D; Nishimura et al., 2012), suggesting that the
fusion protein is functional. To determine the minimum length
of homology arms that is required for HDR in HCT116 cells,
we tested similar donor vectors harboring 80-, 125-, 150-,
or >740-bp homology arms (Figure S2). Surprisingly, even inCell Reports 15, 210–218, April 5, 2016 211
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Figure 2. Construction of Human Conditional AID Mutants
(A) A schematic illustration of the AID system. Expressed OsTIR1 can form a functional SCFOsTIR1 E3 ligase complex with the endogenous components in human
cells (Nishimura et al., 2009). In the presence of auxin, a protein of interest fused with mAID is rapidly degraded upon poly-ubiquitylation.
(B) A schematic illustration showing the strategy of construction of human conditional AID mutants. Initially, parental cells have to be generated by introducing a
transgene encoding OsTIR1 at the safe-harbor AAVS1 locus. By tagging of the both alleles of a target gene of interest with mAID in the parental cells, conditional
AID mutants can be generated.the case of 125-bp homology arms, the insertion was observed
in 22% of G418-resistant clones (n = 36). Conversely, the donor
containing 80-bp homology arms did not work (n = 26 and 35).
These results suggest that the minimum homology length
required for HDR is 125 bp in HCT116 cells.
Parental Cells for Construction of Conditional AID
Mutants
The construction of conditional AID mutants is dependent upon
the introduction of two components into cells. The first compo-
nent is the auxin responsive F-box protein, TIR1, which forms
a functional SCFTIR1 ubiquitin ligase with the endogenous sub-
units conserved in all eukaryotic cells (Figure 2A). In this study,
we used TIR1 derived from Oryza sativa (OsTIR1), because it
worked better than its homolog in A. thaliana at higher tempera-
tures (Nishimura et al., 2009). The second component is the
AID tag that is fused to the protein of interest at the endogenous
locus. We used a 68-aa fragment of the original AID/IAA17
tag termed mini-AID (mAID), the molecular weight of which is
7.4 kDa (Figure 2A; Kubota et al., 2013; Nishimura and Kane-
maki, 2014).
To construct conditional human AID cells, we took a two-step
approach (Figure 2B). We initially generated parental cells by
introducing an expression vector encoding OsTIR1 at the safe
harbor AAVS1 locus using CRISPR/Cas (Mali et al., 2013; Smith212 Cell Reports 15, 210–218, April 5, 2016et al., 2008). Subsequently, an in-framemAID cassette was intro-
duced by CRISPR/Cas into the parental cell line, after the last
codon of the gene of interest. We co-transfected two short ho-
mology donor vectors containing neomycin (Neo) and hygromy-
cin (Hygro) resistance markers, in order to tag both alleles simul-
taneously by selecting cells in the presence of G418 and Hygro
(Figure 2B; Park et al., 2014). In this way, it is possible to generate
conditional AIDmutants by a single transfection and subsequent
cloning of the parental cell line.
We generated two parental lines that expressed OsTIR1
under the control of the constitutive cytomegalovirus (CMV) or
conditional tet promoter (CMV-OsTIR1 or tet-OsTIR1, respecti-
vely)(Figures 3A and 3D). After selection with puromycin,
the genotype was checked by genomic PCR (Figures 3B and
3E). Subsequently, the expression of OsTIR1 was confirmed by
immunoblotting (Figures 3C and 3F). We used a stable clone
that carried a homozygous insertion for the subsequent studies.
To test whether the expression of OsTIR1 and/or the addition of
auxin would cause a side effect, we looked at cell growth and
cell-cycle profile of WT and CMV-OsTIR1 cells in the presence
or absence of auxin (Figure S3). Both WT and CMV-OsTIR1 cells
grew similarly in all culture conditions (Figure S3A). Furthermore,
the cell-cycle profile of the cells with or without auxin was also
similar (Figures S3B and S3C). These results were consistent
with our previous findings that neither OsTIR1 expression nor
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Figure 3. Construction of Parental HCT116 Cells Expressing OsTIR1
(A) Experimental scheme used to introduce CMV-OsTIR1 at the AAVS1 locus. Cells were transfected with pMK232 (AAVS1-CMV-OsTIR1-PURO-AAVS1) and
AAVS1-T2 CRISPR/Cas to target AAVS1 locus (Mali et al., 2013). After integration at the AAVS1 locus, the PCR primers should give rise to 1.2 kb products.
(B) After selection with 1 mg/ml puromycin, 20 clones were checked by genomic PCR.
(C) Immunoblotting to detect OsTIR1. The indicated clones were checked by immunoblotting using an anti-OsTIR1 antibody.
(D) Experimental scheme used to introduce tet-OsTIR1 at the AAVS1 locus. Cells were transfected with pMK243 (AAVS1-tetOsTIR1-PURO-AAVS1) and AAVS1-
T2 CRISPR/Cas to target AAVS1 locus (Mali et al., 2013). After integration at the AAVS1 locus, the PCR primers should give rise to 1.2 kb products.
(E) After selection with 1 mg/ml puromycin, 20 clones were checked by genomic PCR.
(F) Immunoblotting to detect OsTIR1. The indicated clones were grown in the presence of the indicated concentrations of doxycycline for 24 hr before immu-
noblotting using an anti-OsTIR1 antibody. The asterisk indicates a background band.auxin addition significantly affected the expression profile of
mRNA in chicken DT40 cells (Nishimura et al., 2009). We
concluded that the expression of OsTIR1 and the addition of
auxin do not cause a noticeable side effect under our experi-
mental condition.
Conditional AID Allele of the Nuclear Cohesin Complex
To illustrate the efficacy of the AID system for nuclear proteins in
human cells, we targeted the RAD21 ‘‘kleisin’’ subunit of the co-
hesin complex, which is involved in sister chromatid cohesion,
DNA repair, and transcription (Jeppsson et al., 2014). Using
PCR with long oligonucleotides, we constructed two short-arm
donor vectors containingmAID andmonomeric Clover (mClover)
with a Neo or Hygro resistance marker (Figure 4A; Lam et al.,
2012). The two donors were mixed and transfected togetherwith a CRISPR/Cas vector, to insert the AID cassette after the
last codon of the RAD21 gene in wild-type and CMV-OsTIR1
cells. After double selection with G418 and Hygro, we isolated
clones and checked the insertion by genomic PCR (Figure 4B).
We found that more than 70% of clones that were resistant to
G418 and Hygro showed homozygous insertion of the AID
cassette at the correct locus, and we confirmed that these cells
expressed RAD21-mAID-mClover (RAD21-mAC) in the nucleus
(Figure S4).
After treating cells with auxin, we found that the RAD21-mAC
protein was depleted very efficiently, specifically in cells express-
ing OsTIR1 (Figure 4C). Importantly, the auxin-induced depletion
of RAD21-mAC was very rapid, with a half-life of 17 min (Figures
4D and S4). Correspondingly, cells exhibited immediate growth
arrest upon depletion of RAD21-mAC (Figure 4E). In contrast,Cell Reports 15, 210–218, April 5, 2016 213
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Figure 4. Conditional AID Mutant of RAD21, the Kleisin Subunit of the Cohesin Complex
(A) Experimental scheme used to generate RAD21-mAC cells. A PCR-amplified DNA carrying 180- and 175-bp homology arms was cloned into pCR-BluntII-
TOPO. Donor vectors harboring Neo or Hygro were mixed before transfection with a CRISPR/Cas vector to target the RAD21 locus.
(B) Genomic PCR to test the genotype of clones after G418 and hygromycin selection. Primer sets and expected PCRproducts are shown in the illustration shown
on the left.
(C) Detection of the RAD21-mAC protein using anti-RAD21 and anti-mAID antibodies. The indicated cells were treated with or without 500 mM of IAA for 24 hr
before protein extraction.
(D) mClover signals were quantified after the addition of 500 mM of IAA (+ auxin) or DMSO ( auxin) by capturing time-lapse images at the indicated time points.
(E) The indicated cells were treated with 500 mM of IAA (+ auxin) or DMSO ( auxin) at 0 hr. The number of cells was counted at the indicated time points.the growth of RAD21-mAC cells without OsTIR1 was unaffected,
which indicated that auxin itself does not inhibit cell growth. These
results showed that, combined with the CRISPR/Cas technology,
short-arm donors can be used for the generation of human AID
mutants.
AID Tagging Allows Rapid Depletion of the Cytoplasmic
Dynein Complex
To show that the AID system can also be used to deplete essen-
tial human proteins that are localized in the cytoplasm, we tar-
geted the gene encoding the dynein heavy chain 1 (DHC1) pro-
tein. This is one of the main components of the cytoplasmic
dynein complex, which carries cargo and is essential for estab-
lishing chromosome bi-orientation during metaphase (Firestone
et al., 2012; Raaijmakers et al., 2013). We constructed two short
homology donor vectors containingmAID-mClover with a Neo or
Hygro resistance marker using gene synthesis (Figure 5A). We
also constructed similar donor vectors harboring 1-kb homology
arms that were cloned from the genome.
We initially transfected the short- or long-arm donors into
CMV-OsTIR1 cells, using CRISPR/Cas to insert the AID cassette
after the last codon of the DHC1 gene. However, very few col-
onies grew after selection with G418 and Hygro (Figure S5).
We noted previously that the level of AID-fused proteins was214 Cell Reports 15, 210–218, April 5, 2016reduced slightly in yeast and human cells expressing OsTIR1,
even in the absence of auxin (data not shown), probably reflect-
ing the basal activity of the SCFOsTIR1 E3 ubiquitin ligase. To
overcome this problem, we transfected the same DHC1 donor
and CRISPR/Cas vectors into tet-OsTIR1 cells under the repres-
sive condition. After selection with G418 and Hygro, many col-
onies were formed (Figure S5), regardless of whether we used
short- or long-homology arms. In both cases, more than 86%
of the isolated clones carried a homozygous insertion (Figure 5B),
which indicates that short-arm donors work as efficiently as
long-arm donors. We also confirmed that most G418 and Hygro
resistant clones exhibited arrested growth in the presence of
doxycycline (dox) and auxin, which suggests that in-frame inser-
tion occurred very efficiently (data not shown). We used a clone
that was generated using the short-arm donors for subsequent
analysis.
We added dox and auxin to induce the expression of OsTIR1
and the degradation of DHC1-mAIC-mClover (DHC1-mAC),
respectively, followed by the collection of time-course samples.
Immunoblotting showed that OsTIR1 expression was induced
from 2 hr and reached a plateau at 10 hr (Figure 5C). Corre-
spondingly, the DHC1-mAC protein was depleted. Considering
that themolecular weight of DHC1 is 530 kDa, this result showed
that very large proteins can be efficiently depleted using AID
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Figure 5. Conditional AID Mutant of DHC1, the Main Subunit of the Cytoplasmic Dynein Complex
(A) Experimental scheme used to generate DHC1-mAC cells. Two donor plasmids harboring 180- and 175-bp homology arms were constructed using gene
synthesis and sub-cloning. The donors were mixed before transfection with a CRISPR/Cas vector to target the DHC1 locus.
(B) Genomic PCR to test the genotype of clones after G418 and hygromycin selection. Primer sets and expected PCRproducts are shown in the illustration shown
on the left.
(C) Detection of DHC1 and OsTIR1 using anti-DHC1 and anti-OsTIR1 antibodies, respectively. DHC1-mAC cells were treated with 2 mg/ml doxycycline and
500 mM of IAA.
(D) DHC1-mAC cells were treated with 2 mg/ml doxycycline or 2 mg/ml doxycycline and 500 mM IAA at 0 hr. The number of cells was counted at the indicated time
points.
(E) DHC1-mAC cells were treated with 1 mg/ml tetracycline and 500 mM IAA. Mitotic cells with condensed chromosomes and a round cell shape were counted at
18 and 42 hr (n > 500).
(F) The DHC1-mAC cells used in Figure 5E were fixed at 18 hr and stained with an anti-tubulin antibody (green) and SiR Hoechst (magenta) before observation.
The scale bar represents 10 mm.technology. We then analyzed cell proliferation after the addition
of dox, or dox and auxin (Figure 5D). In the presence of dox and
auxin, the cells exhibited completely arrested proliferation at
48 hr. We noted that the cells treated with dox alone also showed
slowed proliferation, although the effect was not as strong as
that observed in cells treated with dox and auxin. This was
consistent with the notion that SCFOsTIR1 somewhat reduced
the expression level of AID-fused proteins, even without auxin,
and with our finding that DHC1-mAC cells were not generated
in the CMV-OsTIR1 background. We conducted a similar exper-
iment using tetracycline (tet) instead of dox, and we checked
chromosomes and cell morphology (Figures 5E and 5F). After
the addition of tet and auxin, mitotic cells accumulated, in which
chromosomes were misaligned. This phenotype was consistent
with previous findings of loss of DHC1 function by small inter-
fering RNA (siRNA) or inhibitor treatment, which caused chromo-
some misalignment and mitotic arrest (Firestone et al., 2012;Raaijmakers et al., 2013). Overall, these findings indicated that
conditional AID mutants can be generated in human cells for
essential nuclear and cytoplasmic proteins, using synthetic
short-arm donors.
Tagging with Short-Arm Donor Works in Mouse ES Cells
To test whether the CRISPR-based tagging with short-arm do-
nors works in other cell types, we tagged the MCM2 gene in
mouse ES cells, which have been used for the conventional
gene targeting (Thomas and Capecchi, 1987). We constructed
a donor vector carrying mAID-mClover, a Neo-resistant marker,
and 200-bp homology arms by gene synthesis and one-step
cloning as described in Figure 5A. The donor vector was trans-
fected into mouse ES cells together with a CRISPR/Cas vector
for targeting the C-terminal coding region of the MCM2 gene
(Figure 6A). After selection by G418, colonies were isolated for
genotyping by PCR. We found that at least one allele of theCell Reports 15, 210–218, April 5, 2016 215
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Figure 6. mAID-mClover Tagging of the
MCM2 Protein Using a Donor Plasmid
Harboring Short Homology Arms in Mouse
ES Cells
(A) Experimental scheme used to tag MCM2 with
mAID-mClover. A donor plasmid harboring 200-bp
homology arms with a neomycin maker was con-
structed using gene synthesis and sub-cloning.
The donor was transfected with a CRISPR/Cas
vector to target the MCM2 locus.
(B) Genomic PCR to test the genotype of clones
after G418 selection. Primer sets and expected
PCR products are shown in (A).
(C) Microscopic observation of a positive colony.
MCM2-mAID-mClover (MCM2-mAC) localized in
the nucleus was detected under a fluorescent
microscope.MCM2 genewas tagged in 50%ofG418-resistant clones (n = 32)
(Figure 6B). Consistent with this result, we noted that 50% of
colonies were mClover positive (Figure 6C; data not shown).
Based on these results, we conclude that tagging with short-
arm donors efficiently works even in mouse ES cells and suggest
that AID conditional mutants of mouse ES cells can be generated
following a similar strategy described in this paper.
DISCUSSION
In this report, we showed that it is possible to tag endogenous
genes in human HCT116 and mouse ES cells, using donor
vectors harboring short homology arms. As shown in Figure S2,
the minimum homology length required for tagging MCM8 in
HCT116 was 125 bp. However, the minimum length might vary
depending on the locus of the gene of interest. Using 175- to216 Cell Reports 15, 210–218, April 5, 2016220-bp homology arms, we have suc-
cessfully tagged more than ten endoge-
nous proteins in HCT116 cells to date.
To place fluorescent, purification, or
mAID tags at the C terminus of a protein
of interest, we generated a series of plas-
mids for the construction of donor vec-
tors, using PCR or via simple cloning after
gene synthesis (Figure S6).
We used two types of parental HCT116
cells in which OsTIR1 expression was
driven by the constitutive CMV or the con-
ditional tet promoter (Figure 3). As typified
by DHC1 (Figure S5), there are cases in
which we have been unable to generate
AID mutants in the CMV-OsTIR1 back-
ground, possibly because of the reduced
expression of the AID-fused protein, due
to the basal activity level of CMV-ex-
pressed OsTIR1. Therefore, it will be help-
ful to test both parental cell lines for the
generation of new AID conditional mu-
tants. The addition of auxin induces the
rapid degradation of AID-fused proteins,
typically with a half-life of 10–20 min(Holland et al., 2012; Lambrus et al., 2015; Nishimura et al.,
2009). Consistently, Figure 4D showed that the half-life of
RAD21-mAC was 17 min in the presence of auxin. In the case
of the tet-OsTIR1 background, an initial period of 10 hr is
required to induce the maximum expression level of OsTIR1,
following the addition of either doxycycline or tetracycline (Fig-
ure 5C). To deplete AID-fused proteins as quickly as possible
when using the tet-OsTIR1 system, pre-induction of OsTIR1
before auxin addition is likely to be helpful.
We used HCT116 cells for knockin experiments because of
their high efficiency of HDR and their diploid karyotype (Wald-
man et al., 1995). Therefore, it is necessary to test whether the
short-arm donors are efficient for CRISPR/Cas-mediated HDR
in other cell types. We expect that the same tagging strategy
can be applied to cell lines that are used for conventional gene
targeting, such as human NALM6 cells, chicken DT40 cells,
and other types of cells. In fact, we successfully showed that
short-arm-donor-based tagging worked in mouse ES cells
(Figure 6). Our tagging method using donors harboring short
synthetic homology arms employs the conventional HDR
pathway and can be used as an alternative to the recently
described tagging method that uses micro-homology-mediated
end-joining repair (Nakade et al., 2014). Overall, in combination
with the CRISPR/Cas technology, our strategy facilitates gene
tagging at endogenous loci and opens the door to the possibility
of generating genome-wide conditional AID mutants for all
essential genes in human cells.
EXPERIMENTAL PROCEDURES
Plasmid Construction
We used pX330-U6-Chimeric_BB-CBh-hSpCas9 from Feng Zhang (Addgene
#42230; Cong et al., 2013) to construct CRISPR/Cas vectors according to the
protocol of Ran et al. (Ran et al., 2013). To construct donor plasmids for the
expression of OsTIR1 from the AAVS1 locus, AAVS1 hPGK-Puro-pA from
Rudolf Jaenisch (Addgene #22072; Hockemeyer et al., 2009) was modified.
The CMV and tet promoters from pIRES2-AcGFP (Clontech) and ptet-One
(Clontech), respectively, the SV40 terminator from pIRES2-AcGFP, and a
codon-optimized OsTIR1 gene were used. The template plasmids shown in
Figure S6A were based on pBluescript and constructed using synthesized
DNA and genes encoding mClover and mCherry2 from Michael Lin (Addgene
#40259; Lam et al., 2012) and Michael Davidson (Addgene #54517), respec-
tively. An experimental overview of the construction of donor vectors is pre-
sented in Figure S6B. To construct donor vectors by PCR (Figures 1A and
4A), the template DNA was amplified using Phusion DNA polymerase (New
England Biolabs) and 200-base oligonucleotides containing a 175-base ho-
mology sequence to the target locus. Amplified DNA was cloned at the EcoRV
site of pBluescript or into pCR Blunt II-TOPO (Thermo Fisher Scientific). To
construct donor vectors via gene synthesis (Figure 5A), homology arms that
were split by the BamHI sequence were synthesized. The mAID-mClover
cassette containing a selection marker was excised by BamHI and cloned at
the BamHI site, between the homology arms. In all cases, homology arms
were designed to introduce a silent mutation or to delete partly the recognition
sequence after integration at the target locus, to prevent re-cutting. All plas-
mids shown in Figure S6A are available from Addgene (https://www.
addgene.org) and the Gene Engineering Division of the National Bioresource
Project (http://dna.brc.riken.jp).
Cell Culture, Transfection, and Colony Isolation
The original HCT116 cells were obtained from American Type Culture Collec-
tion (ATCC CCL-247) and were cultured in McCoy’s 5A medium (Thermo
Fisher Scientific) supplemented with 10% FBS (Gibco), 2 mM L-glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin. Cells were grown in a 37C
humid incubator with 5% CO2. To generate stable cell lines, cells were grown
in a six-well plate before CRISPR/Cas and donor plasmids were transfected
using FuGene HD (Promega). Two days after transfection, cells were removed
and diluted in 10-cm dishes, followed by selection in the presence of 1 mg/ml
puromycin, 700 mg/ml G418, and/or 100 mg/ml HygroGold. After 10–12 days,
colonies were picked for further selection in a 96-well plate. To induce the
degradation of AID-fused proteins, 500 mM indole-3-acetic acid (IAA), a natural
auxin, was added to the culture medium. In Figure 6, mouse TT2 ES cells were
used following the culture method as previously described (Yagi et al., 1993).
After transfection, ES cells were selected in the presence of 300 mg/ml G418
for 8 days. Detailed methods for transfection, selection, and colony isolation
of human HCT116 and mouse ES cells are described in Supplemental Exper-
imental Procedures. HCT116 cell lines expressing OsTIR1 are available from
the Cell Bank of the National Bioresource Project (http://cell.brc.riken.jp/en/).
Genomic PCR
To prepare genomic DNA, cells were lysed in lysis solution (100 mM Tris-HCl
[pH 8.0], 200 mM NaCl, 5 mM EDTA, 1% SDS, and 0.6 mg/ml proteinase K),followed by incubation at 55C for 1 hr. After isopropanol precipitation, DNA
pellets were washed in 70% ethanol before re-suspension in TE containing
50 mg/ml RNase A. The DNA solution was incubated at 37CO/N, for degrada-
tion of RNA. Genomic PCR was carried out using Tks Gflex DNA polymerase
(TaKaRa) according to the manufacturer’s instruction and 30 cycles of the
following protocol: 98C, 10 s/ 55C, 15 s/ 68C, 0.5 min/kb.
Protein Detection
To prepare protein extracts, cells were collected and washed with PBS before
lysing in RIPA buffer (25 mM Tris-HCl [pH 7.6], 150 mM NaCl, 1% Nonidet
P-40, 1% sodium deoxycholate, and 0.1% SDS) containing a protease inhib-
itor cocktail (Complete EDTA free; Roche). Protein concentration was checked
using the Bradford assay before adding 23 SDS sample buffer (125 mM Tris-
HCl [pH 6.8], 4% SDS, 20% glycerol, 0.01% bromophenol blue, and 10%
2-mercaptoethanol). After denaturation at 95C for 5 min, equal amounts of to-
tal protein were separated using SDS-PAGE. Proteins were transferred to a
Hybond ECL membrane (GE Healthcare) and blotted with antibodies after
blocking in 5% skim milk/TBST for 1 hr at room temperature. Detection was
performed using the Amersham ECL Prime reagents (GE Healthcare) with a
ChemiDoc Touch system (Bio-Rad). Anti-MCM8 and anti-OsTIR1 polyclonal
antibodies raised in-house were used for the detection of MCM8 and OsTIR1,
respectively (Nishimura et al., 2012). To detect mAID, RAD21, and DHC1, com-
mercial antibodies (MBL M214-3, MBL K0202-3, and Santa Cruz sc-9115,
respectively) were used.
Microscopy
To detect the GFP and mClover signals shown in Figure 1D and Figure S4,
respectively, we captured images of live cells using a DeltaVision deconvolu-
tion microscope (GE Healthcare) equipped with an incubation chamber and a
CO2 supply system. Cells were cultured in supplemented McCoy’s medium
without phenol red. To visualize nuclei, 1 mg/ml Hoechst 33342 was added
before observation. To detect mClover signals shown in Figure 6C, we used
a fluorescent IX70microscope (Olympus). To acquire the images shown in Fig-
ure 5F, cells were fixed with 3% paraformaldehyde and stained with a 5003
diluted anti-a-tubulin antibody (T9026, clone DM1a; Sigma-Aldrich) and
50 mM SiR-Hoechst (Spirochrome) before observation under a Nikon Ti-E
microscope equipped with a Yokogawa CSU-W1 spinning-disk confocal
scanner.
Flow Cytometry
Cells were harvested and fixed in 70% EtOH. Fixed cells were washed and re-
suspended in PBS containing 1% BSA, 50 mg/ml RNase A, and 40 mg/ml pro-
pidium iodide. After incubation at 37C for 30 min, treated cells were filtered
through a nylon mesh filter (pore size 42 mm) for analysis by the Accuri C6
FACS machine (BD) equipped with FCS4 Express Cytometry software (De-
Novo Software).
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